Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Response.
Clin Cancer Res. 2023 Mar 14;29(6):1158-1159. doi: 10.1158/1078-0432.CCR-23-0164.
Clin Cancer Res. 2023.
PMID: 36916192
No abstract available.
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Marmouset V, Decroocq J, Garciaz S, Etienne G, Belhabri A, Bertoli S, Gastaud L, Simand C, Chantepie S, Uzunov M, Genthon A, Berthon C, Chiche E, Dumas PY, Vargaftig J, Salmeron G, Lemasle E, Tavernier E, Delage J, Loirat M, Morineau N, Blanc-Durand F, Pautier P, Vergé V, Auger N, Thomas M, Stefani L, Lepelley M, Boyer T, Thepot S, Gourin MP, Bourquard P, Duchmann M, Morice PM, Michallet M, Adès L, Fenaux P, Récher C, Dombret H, Pagès A, Marzac C, Leary A, Micol JB; UNIHEM, French Network of Pharmacovigilance Centers, ALFA, FILO, and GFM.
Marmouset V, et al.
Clin Cancer Res. 2022 Dec 1;28(23):5211-5220. doi: 10.1158/1078-0432.CCR-22-1622.
Clin Cancer Res. 2022.
PMID: 36201165
Item in Clipboard
The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm.
Marmouset V, Joris M, Merlusca L, Beaumont M, Charbonnier A, Marolleau JP, Gruson B.
Marmouset V, et al.
Hematol Oncol. 2019 Oct;37(4):487-489. doi: 10.1002/hon.2671. Epub 2019 Sep 4.
Hematol Oncol. 2019.
PMID: 31465531
Item in Clipboard
Cite
Cite